| Journal | The Journal of pediatrics |
| Study Type | Clinical Study |
| Population | Human participants |
This is the first large-scale national analysis comparing pediatric toxicity profiles between traditional delta-9 THC products and emerging hemp-derived cannabinoids. The findings reveal clinically significant differences in severe adverse events that directly impact emergency medicine protocols and parental counseling.
This retrospective analysis of the National Poison Data System examined 11,836 unintentional ingestions in children ≤5 years (9,667 delta-9 THC, 2,169 hemp-derived cannabinoids) from 2023-2024. Hemp-derived cannabinoid exposures showed statistically higher rates of respiratory depression (5.9% vs 4.6%) and hypotension (3.87% vs 2.97%) compared to delta-9 THC ingestions. The hemp-derived group also required vasopressor support nearly three times more frequently (0.37% vs 0.13%), suggesting more severe cardiovascular compromise. These products often contain novel synthetic cannabinoids with limited safety data and unpredictable pharmacokinetics.
“I’m seeing more parents assume hemp-derived products are ‘safer’ because they’re federally legal, but this data suggests the opposite may be true for accidental pediatric exposures. The increased respiratory and cardiovascular toxicity with hemp-derived cannabinoids demands heightened clinical vigilance.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
Table of Contents
- FAQ
- Are hemp-derived cannabinoids more dangerous than Δ9-THC for pediatric exposures?
- What age group is most at risk for these unintentional exposures?
- How common are pediatric hemp-derived cannabinoid exposures compared to Δ9-THC?
- What should emergency physicians monitor for in suspected hemp-derived cannabinoid ingestions?
- Are hemp-derived cannabinoids legal and easily accessible to families?
FAQ
Are hemp-derived cannabinoids more dangerous than Δ9-THC for pediatric exposures?
Yes, this study found that hemp-derived cannabinoids (like Δ8-THC, Δ10-THC, THC-O) caused significantly higher rates of respiratory depression (5.9% vs 4.6%) and hypotension (3.87% vs 2.97%) compared to Δ9-THC exposures. Vasopressor use was also nearly three times more frequent in the hemp-derived cannabinoid group (0.37% vs 0.13%).
What age group is most at risk for these unintentional exposures?
This study focused on children 5 years and younger, representing the highest-risk population for unintentional cannabis edible ingestions. Young children in this age group are particularly vulnerable due to their tendency to explore by putting objects in their mouths and their inability to distinguish edible cannabis products from regular food items.
How common are pediatric hemp-derived cannabinoid exposures compared to Δ9-THC?
Between January 2023 and December 2024, poison control centers documented 2,169 cases of hemp-derived cannabinoid exposures compared to 9,667 Δ9-THC cases in children ≤5 years. While hemp-derived cannabinoid exposures are less frequent, they represent a significant and growing public health concern given their increased severity.
What should emergency physicians monitor for in suspected hemp-derived cannabinoid ingestions?
Emergency physicians should closely monitor respiratory status and blood pressure, as hemp-derived cannabinoids show higher rates of respiratory depression and hypotension than traditional Δ9-THC products. Be prepared for potential vasopressor support and consider more intensive monitoring protocols for these exposures compared to standard cannabis ingestions.
Are hemp-derived cannabinoids legal and easily accessible to families?
Many hemp-derived cannabinoids exist in legal gray areas and are widely available in retail stores, gas stations, and online without the same regulatory oversight as traditional cannabis products. This accessibility, combined with marketing that may appear child-friendly, increases the risk of unintentional pediatric exposures in households where parents may not recognize these products as potentially harmful.
